MedTrace Logo

Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients

NCT01202045 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2013-07-08

No results posted yet for this study

Summary

The purpose of this study is to assess the value in terms of sensitivity, specificity and likelihood ratio of the stress echocardiography in the screening of pulmonary arterial hypertension in patients with systemic sclerosis and indirect signs of pulmonary arterial hypertension.

Conditions

  • Scleroderma, Systemic
  • Hypertension, Pulmonary

Sponsors & Collaborators

  • Paul Farand

    lead OTHER

Principal Investigators

  • Paul Farand, md, msc · Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01202045 on ClinicalTrials.gov